PARP14, a member of the glycosyltransferase family, has been shown to be closely associated with the development of a number of tumors, particularly in pancreatic cancer, hepatocellular carcinoma, and hematologic malignancy [17, 18, 28–30]. This evidence concerns the gene PARP14 and familial pancreatic carcinoma.